Guidelines

P33 Use of Ibrutinib for Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice: Results from the Belgian Ibrutinib Real-World Data (BiRD) Study

February 2018
P34 A crépinette sign

February 2018
P35 PD-1 blockade in a patient with relapsed Hodgkin lymphoma post-allogeneic hematopoietic cell transplant: complete metabolic response without graft-versus-host-disease

February 2018
P36 Can CLL-IPI at time of diagnosis predict who may never need treatment for B-CLL?

February 2018
P37 Comparison of Multigam^® IV (5% vs. 10%) in hematological patients with secondary immunodeficiencies to evaluate infusion time, tolerability and satisfaction. A monocentric observational Belgian study

February 2018
P44 Incidence trends of hematological malignancies in belgium over 2004–2015: impact of the residence on chronic myeloid disorders

February 2018
P45 Donor cell derived deletion 7q occurring after allogeneic stem cell transplantation: a case report

February 2018
P46 About a case of allogenic hematopoietic stem cell transplant-associated thrombotic microangiopathy

February 2018
P49 Evaluation of the CellaVision DM96 Advanced RBC Application for screening and follow-up of malaria infection

February 2018
P50 Resolving DOAC interference on lupus anticoagulant testing: evaluation of DOAC-Stop®

February 2018

Top